激励计划

Search documents
众辰科技: 关于向公司2025年第二期限制性股票激励计划激励对象授予限制性股票的公告
Zheng Quan Zhi Xing· 2025-07-04 16:34
Core Points - The company has approved the grant of 406,500 restricted stocks under the 2025 Second Phase Restricted Stock Incentive Plan, with a grant date set for July 4, 2025, and a grant price of 20.55 yuan per share [1][8][10] Group 1: Incentive Plan Details - The incentive plan was approved by the board and has undergone necessary decision-making procedures and disclosures [1][2] - The plan includes specific conditions that must be met for the grant of restricted stocks, ensuring compliance with relevant laws and regulations [2][4] - The plan's effective period is from the grant date until all restricted stocks are either released from restrictions or repurchased, lasting no more than 48 months [5][9] Group 2: Vesting Schedule - The restricted stocks will have a vesting period divided into three phases: 30% after 12 months, 30% after 24 months, and 40% after 36 months [5][6] - During the vesting period, the stocks cannot be transferred or used as collateral [5][9] Group 3: Financial Impact - The incentive plan is expected to have a financial impact on the company's annual results, with estimated costs to be amortized over the years 2025 to 2028 [9][10] - The company anticipates that the positive effects of the incentive plan on performance will outweigh the costs associated with stock compensation [9][10] Group 4: Legal Compliance - The plan has been verified by a legal firm, confirming that it complies with relevant laws and regulations, and that all necessary approvals have been obtained [10]
水晶光电: 关于召开2025年第二次临时股东大会的通知
Zheng Quan Zhi Xing· 2025-07-04 16:33
证券代码:002273 证券简称:水晶光电 公告编号:(2025)037 号 浙江水晶光电科技股份有限公司 关于召开 2025 年第二次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确和完整,没有虚假记载、 误导性陈述或重大遗漏。 根据浙江水晶光电科技股份有限公司(以下简称"公司")第六届董事会第三十一次会 议决议决定,公司定于 2025 年 7 月 21 日(星期一)下午 14:00 召开 2025 年第二次临时股 东大会。现将有关事项通知如下: 一、 召开会议的基本情况 规章、规范性文件和公司章程的规定。 (2)网络投票时间:2025 年 7 月 21 日(星期一) 其中,通过深圳证券交易所系统进行网络投票的时间为 2025 年 7 月 21 日上午 9:15— 为 2025 年 7 月 21 日 9:15—15:00 期间的任意时间。 公司将通过深圳证券交易所交易系统和互联网投票系统(http://wltp.cninfo.com.cn)向 公司股东提供网络形式的投票平台,公司股东可以在网络投票时间内通过上述系统行使表决 权。 公司股东应选择现场投票、网络投票中的一种方式,如果同一表 ...
水晶光电: 第六届监事会第二十一次会议决议公告
Zheng Quan Zhi Xing· 2025-07-04 16:33
证券代码:002273 证券简称:水晶光电 公告编号:(2025)035 号 经审议,监事会认为公司制定的《2025 年限制性股票激励计划(草案)》及其摘要的 内容符合《中华人民共和国公司法》《中华人民共和国证券法》《上市公司股权激励管理办 法》《深圳证券交易所股票上市规则》《深圳证券交易所上市公司自律监管指南第 1 号—— 业务办理》等有关法律、行政法规、规范性文件以及《公司章程》的规定,履行了相关的法 定程序。公司实施 2025 年限制性股票激励计划(以下简称"本次激励计划"),有利于建 立、健全公司长效激励机制,实现公司、股东与经营管理者之间的利益共享,不存在损害公 司及全体股东利益的情形。 《浙江水晶光电科技股份有限公司 2025 年限制性股票激励计划(草案)》及其摘要的 公告(公告编号:(2025)036 号)详见信息披露媒体《证券时报》《中国证券报》《上海 证券报》《证券日报》和信息披露网站巨潮资讯网 http://www.cninfo.com.cn。 施考核管理办法>的议案》; 浙江水晶光电科技股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确和完整,没有虚假记载、 误导性陈述或重 ...
水晶光电: 第六届董事会薪酬与考核委员会关于公司2025年限制性股票激励计划相关事项的核查意见
Zheng Quan Zhi Xing· 2025-07-04 16:33
浙江水晶光电科技股份有限公司 第六届董事会薪酬与考核委员会 计报告; 审计报告; 形; 公司具备实施股权激励计划的主体资格。 二、本激励计划的激励对象不存在《管理办法》规定的不得成为激励对象的以下情形: 市场禁入措施; 关于公司 2025 年限制性股票激励计划相关事项的核查意见 浙江水晶光电科技股份有限公司(以下简称"公司")第六届董事会薪酬与考核委员会 根据《中华人民共和国公司法》(以下简称"《公司法》")、《中华人民共和国证券法》 (以下简称"《证券法》")、 《上市公司股权激励管理办法》 (以下简称"《管理办法》") 等相关法律法规、规范性文件和《公司章程》的有关规定,对公司《2025 年限制性股票激 励计划(草案)》(以下简称"《激励计划(草案)》"或"本激励计划")及其相关事项 进行了核查,发表核查意见如下: 一、公司不存在《管理办法》等法律法规、规范性文件规定的禁止实施股权激励计划的 下列情形: 综上所述,我们同意公司实施本次激励计划。 浙江水晶光电科技股份有限公司第六届董事会 薪酬与考核委员会 [本页无正文,为第六届董事会薪酬与考核委员会关于公司 2025 年限制性股票激励计划相 关事项的核查意 ...
索辰科技: 北京市中伦律师事务所关于公司2025年限制性股票激励计划的法律意见书
Zheng Quan Zhi Xing· 2025-07-04 16:23
Core Viewpoint - The legal opinion letter from Beijing Zhonglun Law Firm confirms that Shanghai Suochen Information Technology Co., Ltd. is eligible to implement its 2025 restricted stock incentive plan, adhering to relevant laws and regulations [2][4][21]. Group 1: Company Overview - Company Name: Shanghai Suochen Information Technology Co., Ltd. [8] - Unified Social Credit Code: 91310000785643574Y [8] - Registered Capital: 89.108784 million yuan [8] - Established Date: February 24, 2006 [8] - Company Type: Joint-stock company (listed, natural person investment or control) [8] Group 2: Incentive Plan Details - The incentive plan involves granting up to 693,511 restricted stocks, accounting for approximately 0.7783% of the company's total share capital [12]. - The first grant will consist of 554,809 restricted stocks, representing about 0.6226% of the total share capital [12]. - The plan includes provisions for the management of the incentive program, including eligibility criteria, stock allocation, and vesting conditions [11][16]. Group 3: Legal Compliance and Procedures - The company has fulfilled necessary legal procedures for the implementation of the incentive plan, including board and supervisory committee approvals [17][21]. - The plan has been reviewed and approved by the remuneration and assessment committee, which believes it will benefit the company's sustainable development [23]. - The company has committed not to provide financial assistance to the incentive plan participants [21][23]. Group 4: Impact on Shareholders - The incentive plan is designed to align the interests of the incentive recipients with those of the shareholders, ensuring no significant harm to shareholder interests [23][24]. - The plan's procedures have been established to maintain transparency and protect shareholder rights [23][24].
罗普特: 罗普特科技集团股份有限公司关于2024年限制性股票激励计划预留权益失效的公告
Zheng Quan Zhi Xing· 2025-07-04 16:22
证券代码:688619 证券简称:罗普特 公告编号:2025-039 罗普特科技集团股份有限公司 罗普特科技集团股份有限公司(以下简称"公司")于 2024 年 7 月 4 日召 开 2024 年第一次临时股东大会,审议通过了《关于 <公司 ensp="ensp" 年限制性股票激="年限制性股 票激"> 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 励计划(草案)>及其摘要的议案》(以下简称"本激励计划")。本激励计划 中规定的预留授予第二类限制性股票数量为 322,500 股,占本激励计划拟授予 权益总数的比例为 20%。预留权益(322,500 股)因未在 2024 年第一次临时股 东大会通过本次激励计划后 12 个月内明确激励对象而失效。现将有关事项说明 如下: 一、 2024 年限制性股票激励计划已履行的决策程序和信息披露情况 了《关于 <公司 ensp="ensp" 年限制性股票激励计划="年限制性股票激励计划" 草案="草案"> 及其摘要 的议案》《关于 <公司 ensp="ensp" 年限制性股票激励计划实施考 ...
上海医药: 上海医药集团股份有限公司关于2019年A股股票期权激励计划预留股票期权第三个行权期2025年第二季度自主行权结果公告
Zheng Quan Zhi Xing· 2025-07-04 16:22
Core Points - The announcement details the results of the third exercise period for the stock option incentive plan of Shanghai Pharmaceuticals, indicating that no options were exercised during the second quarter of 2025 [4][11] - The total number of stock options available for the third exercise period is 680,000, with the exercise period running from February 8, 2025, to February 7, 2026 [4][11] - The company has followed all necessary approval procedures for the stock option incentive plan, including independent opinions from directors and the supervisory board [2][3][5] Approval Process - The company’s board approved the stock option incentive plan and its management measures, with independent directors providing their opinions and the supervisory board conducting necessary checks [2][3][5] - The plan was initially approved by the State-owned Assets Supervision and Administration Commission [1][2] Exercise Details - As of the second quarter of 2025, the number of individuals eligible to exercise the options is 20, but none have exercised their options [7][11] - The stock options are to be issued as ordinary shares (A-shares) to the incentive targets [7][9] Impact on Financials - The lack of exercised options during the third exercise period has not had a significant impact on the company's financial status or operating results as of the end of the second quarter of 2025 [11]
显盈科技: 监事会关于公司2025年限制性股票激励计划相关事项的核查意见
Zheng Quan Zhi Xing· 2025-07-04 16:22
Core Viewpoint - The company is set to implement a restricted stock incentive plan for 2025, which aims to attract and retain talent while aligning the interests of shareholders, the company, and core team members [1][4]. Group 1: Eligibility and Compliance - The company meets the qualifications to implement the stock incentive plan and does not fall under any prohibitive conditions outlined in relevant laws and regulations [1][3]. - The incentive plan's participants do not include independent directors, supervisors, or shareholders holding more than 5% of the company's shares [1][2]. Group 2: Incentive Plan Details - The plan includes an international participant, Mao Dan yun, who is the Vice President and leads the R&D department, contributing significantly to the company's technological advancements [2]. - The plan's design and review process comply with the relevant laws and regulations, ensuring that the granting and vesting arrangements do not violate any legal provisions [3][4]. Group 3: Benefits of the Incentive Plan - Implementing the restricted stock incentive plan will help establish a long-term incentive mechanism, motivating core management and key personnel, thereby supporting the company's long-term development [4].
捷邦科技: 监事会关于2024年限制性股票与股票期权激励计划首次授予部分第一个归属期可归属及第一个行权期可行权激励对象名单的核查意见
Zheng Quan Zhi Xing· 2025-07-04 16:22
Group 1 - The core viewpoint of the news is that the Supervisory Board of Jebon Precision Technology Co., Ltd. has verified the eligibility of 64 individuals for the first vesting period of the restricted stock and stock options under the 2024 incentive plan, confirming compliance with relevant laws and regulations [1][2] - The first vesting conditions for the restricted stock have been met, allowing for the allocation of 266,700 shares to the eligible individuals [1] - The first exercise conditions for the stock options have also been met, permitting the exercise of 266,700 stock options for the eligible individuals [2] Group 2 - The verification process for both the restricted stock and stock options adheres to the provisions of the Company Law, Securities Law, and the Management Measures for Incentive Plans, ensuring no harm to the interests of the company and its shareholders [1][2] - The eligibility criteria for the incentive plan participants have been confirmed, with all 64 individuals meeting the necessary qualifications as per the relevant regulations [1][2]
德尔玛: 关于调整公司2024年限制性股票激励计划授予价格的公告
Zheng Quan Zhi Xing· 2025-07-04 16:22
证券代码:301332 证券简称:德尔玛 公告编号:2025-029 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 广东德尔玛科技股份有限公司(以下简称"公司"或"德尔玛")于 2025 年 7 月 4 日召开第二届董事会第十次会议和第二届监事会第十次会议,审议通过 了《关于调整公司 2024 年限制性股票激励计划授予价格的议案》,现将有关事 项公告如下: 一、已履行的决策程序和信息披露情况 (一)2024 年 7 月 12 日,公司召开第二届董事会第四次会议,会议审议通 过了《关于公司〈2024 年限制性股票激励计划(草案)〉及其摘要的议案》《关 于公司〈2024 年限制性股票激励计划实施考核管理办法〉的议案》及《关于提 请股东大会授权董事会办理公司 2024 年限制性股票激励计划相关事宜的议案》 等。相关议案已经董事会薪酬与考核委员会审议通过。 (二)2024 年 7 月 12 日,公司召开第二届监事会第四次会议,会议审议通 过了《关于公司〈2024 年限制性股票激励计划(草案)〉及其摘要的议案》《关 于公司〈2024 年限制性股票激励计划实施考核管理办 ...